PROCEPT BioRobotics Corporation
PRCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,197,105 | $1,980,457 | $1,844,376 | $1,092,337 |
| - Cash | $333,725 | $257,222 | $221,859 | $304,320 |
| + Debt | $80,250 | $79,204 | $77,317 | $54,100 |
| Enterprise Value | $3,943,630 | $1,802,439 | $1,699,834 | $842,117 |
| Revenue | $224,498 | $136,191 | $75,014 | $34,473 |
| % Growth | 64.8% | 81.6% | 117.6% | – |
| Gross Profit | $137,099 | $71,049 | $37,085 | $15,865 |
| % Margin | 61.1% | 52.2% | 49.4% | 46% |
| EBITDA | -$81,995 | -$98,095 | -$79,130 | -$50,719 |
| % Margin | -36.5% | -72% | -105.5% | -147.1% |
| Net Income | -$91,413 | -$105,897 | -$87,154 | -$59,853 |
| % Margin | -40.7% | -77.8% | -116.2% | -173.6% |
| EPS Diluted | -1.75 | -2.24 | -1.96 | -3.63 |
| % Growth | 21.9% | -14.3% | 46% | – |
| Operating Cash Flow | -$99,213 | -$108,003 | -$80,382 | -$57,334 |
| Capital Expenditures | -$4,409 | -$25,206 | -$2,653 | -$592 |
| Free Cash Flow | -$103,622 | -$133,209 | -$83,035 | -$57,926 |